186 related articles for article (PubMed ID: 9639059)
21. Agonist interactions with chimeric and mutant beta1- and beta3-adrenergic receptors: involvement of the seventh transmembrane region in conferring subtype specificity.
Granneman JG; Lahners KN; Zhai Y
Mol Pharmacol; 1998 May; 53(5):856-61. PubMed ID: 9584211
[TBL] [Abstract][Full Text] [Related]
22. Real-time monitoring of cAMP in brown adipocytes reveals differential compartmentation of β
Kannabiran SA; Gosejacob D; Niemann B; Nikolaev VO; Pfeifer A
Mol Metab; 2020 Jul; 37():100986. PubMed ID: 32247064
[TBL] [Abstract][Full Text] [Related]
23. Differences in functional cyclic AMP compartments mediating lipolysis by isoprenaline and BRL 37344 in four adipocyte types.
Hollenga C; Brouwer F; Zaagsma J
Eur J Pharmacol; 1991 Aug; 200(2-3):325-30. PubMed ID: 1685995
[TBL] [Abstract][Full Text] [Related]
24. Alpha1- and beta1-adrenoceptor signaling fully compensates for beta3-adrenoceptor deficiency in brown adipocyte norepinephrine-stimulated glucose uptake.
Chernogubova E; Hutchinson DS; Nedergaard J; Bengtsson T
Endocrinology; 2005 May; 146(5):2271-84. PubMed ID: 15665039
[TBL] [Abstract][Full Text] [Related]
25. Mutated human beta3-adrenergic receptor (Trp64Arg) lowers the response to beta3-adrenergic agonists in transfected 3T3-L1 preadipocytes.
Kimura K; Sasaki N; Asano A; Mizukami J; Kayahashi S; Kawada T; Fushiki T; Morimatsu M; Yoshida T; Saito M
Horm Metab Res; 2000 Mar; 32(3):91-6. PubMed ID: 10786926
[TBL] [Abstract][Full Text] [Related]
26. Divergent effects of an alpha2-adrenergic antagonist on lipolysis and thermogenesis: interactions with a beta3-adrenergic agonist in rats.
Gómez-Ambrosi J; Frühbeck G; Aguado M; Milagro FI; Margareto J; Martínez AJ
Int J Mol Med; 2001 Jul; 8(1):103-9. PubMed ID: 11408957
[TBL] [Abstract][Full Text] [Related]
27. Selectivity and potency of agonists for the three subtypes of cloned human beta-adrenoceptors expressed in Chinese hamster ovary cells.
Yanagisawa T; Sato T; Yamada H; Sukegawa J; Nunoki K
Tohoku J Exp Med; 2000 Nov; 192(3):181-93. PubMed ID: 11249148
[TBL] [Abstract][Full Text] [Related]
28. Biochemical and functional characterization of 1-benzyl substituted trimetoquinol affinity analogs on rat and human beta-adrenoceptors.
Mehta RC; Salazar-Bookaman MM; Fertel RH; De Los Angeles J; Nikulin VI; Fraundorfer PF; Miller DD; Feller DR
Biochem Pharmacol; 2000 Mar; 59(5):517-29. PubMed ID: 10660118
[TBL] [Abstract][Full Text] [Related]
29. Age-dependent changes in beta-adrenergic receptor subtypes and adenylyl cyclase activation in adipocytes from Fischer 344 rats.
Gettys TW; Rohlfs EM; Prpic V; Daniel KW; Taylor IL; Collins S
Endocrinology; 1995 May; 136(5):2022-32. PubMed ID: 7720650
[TBL] [Abstract][Full Text] [Related]
30. beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue.
Konkar AA; Zhai Y; Granneman JG
Mol Pharmacol; 2000 Feb; 57(2):252-8. PubMed ID: 10648634
[TBL] [Abstract][Full Text] [Related]
31. Beta2 adrenergic receptors mediate cAMP, tissue-type plasminogen activator and transferrin production in rat Sertoli cells.
Troispoux C; Reiter E; Combarnous Y; Guillou F
Mol Cell Endocrinol; 1998 Jul; 142(1-2):75-86. PubMed ID: 9783905
[TBL] [Abstract][Full Text] [Related]
32. Discovery of a novel and potent human and rat beta3-adrenergic receptor agonist, [3-[(2R)-[[(2R)-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1H-indol-7-yloxy]acetic acid.
Harada H; Hirokawa Y; Suzuki K; Hiyama Y; Oue M; Kawashima H; Kato H; Yoshida N; Furutani Y; Kato S
Chem Pharm Bull (Tokyo); 2005 Feb; 53(2):184-98. PubMed ID: 15684518
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of beta3-adrenergic receptor expression in rat adipose tissue during the fasted/fed transition: evidence for a role of insulin.
Hadri KE; Charon C; Pairault J; Hauguel-De Mouzon S; Quignard-Boulangé A; Fève B
Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):359-64. PubMed ID: 9163324
[TBL] [Abstract][Full Text] [Related]
34. [A change of hormonal regulation of adenylyl cyclase in the epididymal adipose tissue of rats with experimental models of diabetes mellitus].
Derkach KV; Chistyakova OV; Shpakov AO
Zh Evol Biokhim Fiziol; 2014; 50(2):85-91. PubMed ID: 25486812
[TBL] [Abstract][Full Text] [Related]
35. Targeted disruption of the beta 3-adrenergic receptor gene.
Susulic VS; Frederich RC; Lawitts J; Tozzo E; Kahn BB; Harper ME; Himms-Hagen J; Flier JS; Lowell BB
J Biol Chem; 1995 Dec; 270(49):29483-92. PubMed ID: 7493988
[TBL] [Abstract][Full Text] [Related]
36. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation.
Miura S; Kawanaka K; Kai Y; Tamura M; Goto M; Shiuchi T; Minokoshi Y; Ezaki O
Endocrinology; 2007 Jul; 148(7):3441-8. PubMed ID: 17446185
[TBL] [Abstract][Full Text] [Related]
37. Cyclic AMP accumulation in rat soleus muscle: stimulation by beta2- but not beta3-adrenoceptors.
Roberts SJ; Summers RJ
Eur J Pharmacol; 1998 May; 348(1):53-60. PubMed ID: 9650831
[TBL] [Abstract][Full Text] [Related]
38. Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice.
Collins S; Daniel KW; Rohlfs EM; Ramkumar V; Taylor IL; Gettys TW
Mol Endocrinol; 1994 Apr; 8(4):518-27. PubMed ID: 7914350
[TBL] [Abstract][Full Text] [Related]
39. Triiodothyronine and amiodarone effects on beta 3-adrenoceptor density and lipolytic response to the beta 3-adrenergic agonist BRL 37344 in rat white adipocytes.
Germack R; Adli H; Vassy R; Perret GY
Fundam Clin Pharmacol; 1996; 10(3):289-97. PubMed ID: 8836703
[TBL] [Abstract][Full Text] [Related]
40. Role of beta-adrenergic receptor subtypes in lipolysis.
Louis SN; Jackman GP; Nero TL; Iakovidis D; Louis WJ
Cardiovasc Drugs Ther; 2000 Dec; 14(6):565-77. PubMed ID: 11300357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
